Pilot Trial of Humanized Monoclonal Antibody J591 in Patients With Progressive Androgen-Independent Prostate Cancer
Latest Information Update: 09 Nov 2021
At a glance
- Drugs J 591 (Primary) ; J 591-radiolabelled (Primary)
- Indications Prostate cancer
- Focus Pharmacokinetics; Therapeutic Use
- 16 Jun 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 01 Jul 2008 New trial record.